Results 101 to 110 of about 11,472 (199)

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden

open access: yesClinical &Experimental Allergy, EarlyView.
Australia's high allergy burden prompted a national response, leading to the establishment of the National Allergy Centre of Excellence (NACE) in 2022. The NACE has advanced research infrastructure, collaboration, and consumer‐centred care through four pillars, achieving global recognition and accelerating translation into policy, practice, and ...
A. Young   +23 more
wiley   +1 more source

Sesame Immunotherapy: A Systematic Review and Narrative Synthesis

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Sesame allergy is associated with severe allergic reactions, low rates of spontaneous resolution, and significant psychosocial burden. Current management relies on strict avoidance and emergency treatment. Allergen‐specific immunotherapy, particularly oral immunotherapy (OIT), has emerged as a potential disease‐modifying approach, but evidence
Joanna Zielińska   +4 more
wiley   +1 more source

Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

open access: yesClinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Bioassays offer functional readouts of immune responses through specific biomarkers, providing mechanistic insight beyond conventional serology. By capturing cellular activation, tissue‐level changes, and molecular signaling, they hold promise for refining allergy diagnosis, risk stratification, and treatment monitoring, contributing to ...
Cagatay Karaaslan   +13 more
wiley   +1 more source

Ethnomedicinal Uses of Thai Legumes (Fabaceae) and Their Potential in Industrial Applications

open access: yesFood Science &Nutrition, Volume 14, Issue 10, October 2026.
Thai legumes (Fabaceae) are rich sources of bioactive phytochemicals, including saponins, flavonoids, biochanin A, and daidzein. These compounds contribute to diverse ethnomedicinal properties, including antioxidant, antiviral, anti‐inflammatory, anticancer, and cardioprotective activities.
Muhammad Tayyab Arshad   +7 more
wiley   +1 more source

Quinoa and Peanut Extracts as Alternatives to Animal‐Derived Extracellular Matrix Proteins in Cultured Meat Production

open access: yesJournal of Food Science, Volume 91, Issue 10, October 2026.
ABSTRACT Cultured meat, produced through the cultivation of animal cells, represents a sustainable and ethical alternative to traditional livestock farming. The cultivation and expansion of animal cells for cultured meat production rely heavily on extracellular matrix (ECM) proteins, which are needed for cell adhesion, proliferation, and ...
Dominik Mundt   +3 more
wiley   +1 more source

Urinary Lipid Production Profile of Patients With Food Allergy

open access: yes
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 256-259, March 2025.
Sakura Masuko   +10 more
wiley   +1 more source

Is age a critical factor for the diagnosis of peanut allergy in children? [PDF]

open access: yesWorld Allergy Organ J
Bondorevsky O   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy